| Contents | 6 |
---|
| Contributors | 8 |
---|
| Introduction | 12 |
---|
| 1 Establishing Order Within the Cell | 12 |
| 2 Phosphatidylinositol and Phosphoinositides as Ideal Substrates | 13 |
| 3 Nucleating a Protein Complex at a Target Location | 14 |
| 4 Coupling PI3K Activity to Extracellular Cues | 14 |
| 5 Disease Implications | 16 |
| References | 17 |
| PDK1: The Major Transducer of PI 3-Kinase Actions | 19 |
---|
| 1 Introduction | 20 |
| 2 Mechanism of Activation of the AGC Kinases | 20 |
| 2.1 PDK1, the Common T-Loop Kinase | 21 |
| 2.2 mTORC1 and mTORC2, the Hydrophobic Motif Kinases | 22 |
| 2.3 Two Mechanisms of Regulation by PDK1 | 24 |
| 3 Structure of PDK1 | 26 |
| 4 Genetic Models and Disease | 27 |
| 4.1 PDK1 and Diabetes | 27 |
| 4.2 PDK1 and T-Cell Development | 29 |
| 4.3 PDK1, Growth and Cancer | 29 |
| 5 PDK1 as a Druggable Target | 30 |
| 6 Concluding Remarks | 32 |
| References | 33 |
| Protein Kinase B (PKB/Akt), a Key Mediator of the PI3K Signaling Pathway | 40 |
---|
| 1 Classification, Structure, and Substrates of PKB | 41 |
| 2 Regulation of PKB Activity | 42 |
| 2.1 Regulation of PKB Activity by Phosphorylation Events | 42 |
| 2.2 Regulation of PKB Activity by Binding Partners | 44 |
| 2.2.1 PKB Activators | 45 |
| 2.2.2 PKB Inhibitors | 47 |
| 2.2.3 PKB-Interacting Proteins with Undefined Functions | 47 |
| 2.3 Regulation of PKB by CTMP | 48 |
| 3 The Role of PKB in Physiological and Pathological Conditions | 49 |
| 3.1 Effects of Knocking-Out Individual PKB Isoforms in Mice | 50 |
| 3.2 PKB in Embryonic Development | 50 |
| 3.3 PKB in Thymocyte Development | 51 |
| 3.4 PKB in Adipocyte Differentiation | 52 |
| 3.5 PKB in Glucose Homeostasis | 53 |
| 3.6 PKB in Tumor Formation | 55 |
| 4 Conclusion | 56 |
| References | 57 |
| PI3Ks in Lymphocyte Signaling and Development | 66 |
---|
| 1 Introduction | 68 |
| 2 PI3K in B Cells | 71 |
| 2.1 B-Cell Development | 71 |
| 2.2 BcR Signaling, Antigen Presentation, and Metabolism | 72 |
| 2.3 Immunoglobulin Gene Rearrangement and Isotype Switching | 74 |
| 2.4 B-Cell Chemotaxis and Trafficking | 76 |
| 3 PI3K in T Cells | 76 |
| 3.1 T-Cell Development and Differentiation | 76 |
| 3.1.1 A Surprising Redundancy Between p110delta and p110gamma During T-Cell Development | 76 |
| 3.2 TcR Signaling and Costimulation | 77 |
| 3.2.1 PI3K Regulates Some, But Not All, TcR-Dependent Signaling Pathways | 79 |
| 3.3 T-Helper Cell Differentiation | 80 |
| 3.4 Survival and Glucose Homeostasis in Mature T cells | 81 |
| 3.5 PI3K Controls the Development and Suppressive Function of Regulatory T Cells | 81 |
| 3.6 T-Cell Chemotaxis and Migration in Lymph Nodes: Not All About PI3K | 83 |
| 3.7 T-Cell Trafficking | 84 |
| 3.8 Nonessential Role for PI3K in Cytotoxic Responses | 85 |
| 4 Prospects for PI3K Inhibitors in Inflammation and Autoimmunity | 85 |
| References | 86 |
| The Regulation of Class IA PI 3-Kinases by Inter-Subunit Interactions | 95 |
---|
| 1 Structural Organization of p85a/p110a | 96 |
| 2 p85a Inhibits and Stabilizes p110 | 98 |
| 3 Activation of p85a/p110a Dimers by Phosphopeptides | 100 |
| 4 A Mechanism for Phosphopeptide Activation | 101 |
| 5 Activation of p85/p110 by GTPases | 104 |
| 6 Activation by Binding to p85 SH3 and Proline-Rich Domains | 107 |
| 7 Regulation by Autophosphorylation | 107 |
| 8 Oncogenic Mutation of p85a and p110 | 108 |
| 8.1 Helical Domain Mutants: Disruption of the nSH2-Helical Domain Interface | 109 |
| 8.2 The Kinase Domain Mutant H1047R | 110 |
| 8.3 p110a Mutations Disrupting the C2-iSH2 Domain Interface | 110 |
| 8.4 p85a Mutations Disrupting the C2-iSH2 Domain Interface | 111 |
| 9 Regulation of p85/p110 In vivo: Activation Versus Translocation | 112 |
| 10 Unanswered Mechanistic Questions on p85-p110 Interactions | 113 |
| References | 115 |
| Phosphoinositide Signalling Pathways in Metabolic Regulation | 123 |
---|
| 1 Introduction | 124 |
| 2 Role of Insulin Signalling Network Molecules in Metabolic Regulation as Revealed by Global Gene Inactivation in Mice | 125 |
| 3 Role of INSR/PI3K Pathway Components in the Development and Function of Insulin Sensitive Tissues | 131 |
| 3.1 Insulin Sensitive Peripheral Tissues | 131 |
| 3.2 Pancreatic Islets | 134 |
| 3.3 Central Nervous System | 137 |
| 4 Role of the INSR/PI3K Pathway in the Integration of Nutrient Availability and Growth Factor/Hormonal Signals | 139 |
| 5 Molecular Basis of Insulin Resistance Development: Signal Termination Feedback Loops | 140 |
| 6 Discussion | 141 |
| References | 142 |
| Role of RAS in the Regulation of PI 3-Kinase | 150 |
---|
| 1 RAS Proteins | 151 |
| 2 RAS Effectors | 153 |
| 3 RAS-PI3K Interaction | 157 |
| 4 RAS-PI3K in Normal Signalling | 158 |
| 5 RAS-PI3K in Oncogenesis | 160 |
| 6 RAS-PI3K-RAF Pathway Interconnections | 164 |
| 7 Inhibitors | 167 |
| 8 Conclusions | 168 |
| References | 169 |
| More Than Just Kinases: The Scaffolding Function of PI3K | 177 |
---|
| 1 The Double Identity of PI3Kgamma | 178 |
| 1.1 Cardiomyocytes | 179 |
| 1.2 Circulating Endothelial Progenitor Cells | 179 |
| 1.3 Platelets | 180 |
| 2 The Double Identity of PI3Kbeta | 180 |
| 2.1 Cell Growth | 180 |
| 2.2 Metabolism | 182 |
| 2.3 Oncogenesis | 183 |
| 3 The Double Identity of Adaptor Subunits | 183 |
| 4 Conclusions | 184 |
| References | 185 |
| PI3K Signaling in Neutrophils | 188 |
---|
| 1 Neutrophil Biology | 189 |
| 2 Regulation of PI3Ks | 192 |
| 3 Regulation of PtdIns(3,4,5)P3 | 195 |
| 4 Effectors of PI3K Signaling Pathways | 195 |
| 5 Class I PI3K Regulation of Rho Family GTPases in the Context of Cell Spreading and Movement | 196 |
| 6 Class I and Class III PI3K Regulation of the NADPH Oxidase | 198 |
| 7 PI3Ks in Neutrophils as Therapeutic Targets | 201 |
| 8 Conclusions | 202 |
| References | 202 |
| PI 3-Kinase p110beta Regulation of Platelet Integrin aIIbbeta3 | 208 |
---|
| 1 Introduction | 209 |
| 2 Basic Principles of Platelet Adhesion and Activation | 210 |
| 3 Integrin aIIb
|